Evidence Question
What does direct evidence report when empagliflozin is compared with glimepiride for brachial artery flow mediated dilation fmd?
Related to: Cardiovascular RiskShort answer
In indexed direct evidence at the reported timepoint, no difference was reported for brachial artery flow mediated dilation fmd.